(Q83529354)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

D L Kendler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

S Palacios

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

D A Cox

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

J Stock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

J Alam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

S A Dowsett

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

J Zanchetta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

4 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

1091-1101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21374068%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00198-011-1587-0

24 January 2020

exact match

0 references

cites work

Effects of raloxifene therapy on the anticoagulant system in postmenopausal women

1 reference

12 December 2020

Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents

1 reference

12 December 2020

Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene: a novel, highly potent, selective estrogen receptor modulator

1 reference

12 December 2020

Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis

1 reference

12 December 2020

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial

1 reference

12 December 2020

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

1 reference

12 December 2020

LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo

1 reference

12 December 2020

Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?

1 reference

12 December 2020

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

Lasofoxifene in postmenopausal women with osteoporosis

1 reference

12 December 2020

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study

1 reference

12 December 2020

Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature

1 reference

12 December 2020

Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268.

1 reference

12 December 2020

Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis.

1 reference

12 December 2020

The quantitative analysis of mammographic densities

1 reference

12 December 2020

Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer.

1 reference

12 December 2020

Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial

1 reference

12 December 2020

Effects of arzoxifene on bone mineral density and endometrium in postmenopausal women with normal or low bone mass

1 reference

12 December 2020

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

1 reference

12 December 2020

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

12 December 2020

The mechanisms of thrombotic risk induced by hormone replacement therapy

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women

1 reference

12 December 2020